Target intelligence / Profile preview

Physiological Modulation of Tumor Oxygenation (null)

Target
null
Molecular classification
Other
01

Overview

“Physiological modulation of tumor oxygenation” refers to approaches that alter the oxygen levels within tumor tissue to affect cancer progression and response to therapy. Tumor hypoxia promotes resistance to radiotherapy and some drugs, drives malignant phenotypes, and correlates with poor prognosis. Strategies for modulating tumor oxygenation include use of hyperthermia, increasing perfusion, using hyperoxic breathing mixtures, or normalization of blood vessels. This improves radiosensitivity, can reduce metastatic potential, and may facilitate drug delivery and immune infiltration. Molecular pathways influenced by oxygen modulation include HIF signaling, metabolic regulation, and angiogenic cascades. However, this target does not represent a discrete molecular entity but rather a physiological process exploited for therapeutic benefit.

Other names
Tumor oxygenation modulationModulation of tumor hypoxiaOxygen microenvironment manipulation
02

Mechanism of action

Physiological modulation of tumor oxygenation mechanisms include increasing tumor oxygenation to enhance radiosensitivity; modulating blood flow and perfusion to reduce hypoxia; altering metabolic pathways to promote oxidative metabolism; indirectly inhibiting hypoxia-inducible signaling pathways; and normalizing tumor vasculature to enhance oxygen delivery.

03

Biological functions

Modulation of oxygen deliveryRegulation of tumor hypoxiaAlteration of microenvironment pHInfluence on angiogenesis
04

Disease associations

CancerTumor resistance to therapy (as a modulating factor)Other
05

Safety considerations

Tumor adaptation and increased aggressiveness with reoxygenationPotential promotion of tumor growth with excessive angiogenesisTransient normal tissue toxicity from hyperoxia or interventional techniques
06

Interacting drugs

Hyperthermia (as a physical intervention)

4 more in the full profile.

07

Biomarkers

Tumor oxygen partial pressure (pO2)Hypoxia-inducible factor-1 alpha (HIF-1α) expressionRedox status (NAD+/NADH ratio, etc.)Imaging tracers for hypoxia (e.g., [^64Cu]Cu-ATSM)

Beyond the preview

Go deeper on Physiological Modulation of Tumor Oxygenation (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological Modulation of Tumor Oxygenation (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call